Role of vitamin D in controlling vertigo: a review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20241275Keywords:
Vitamin D, Vertigo, Benign paroxysmal positional vertigo, Meniere’s diseaseAbstract
Vertigo is a disabling symptom that has a high recurrence rate and interferes with day-to-day functioning. Vertigo is frequently caused by Meniere's diseases and benign paroxysmal positional vertigo (BPPV). The most prevalent neuro-ontological condition causing vertigo is BPPV. Vertigo attacks that last only a few seconds and are brought on by changing the head's position with respect to gravity are the hallmark of BPPV. There is a suggestion that vitamin D deficiencies and BPPV and Meniere's diseases are positively correlated. However, there is not much awareness among clinicians about association between vitamin D deficiency and certain etiologies of vertigo. After taking vitamin D supplements, vertigo attacks stop happening. Supplementing with vitamin D may be beneficial for patients with low vitamin D levels who have BPPV and Meniere's disease. This review's goal is to discuss about how vitamin D helps to treat vertigo, especially BPPV and Meniere's disease.
Metrics
References
Swain SK, Anand N, Mishra S. Vertigo among elderly people: Current opinion. Journal of Medical Society. 2019;33(1):1-5.
Skøien AK, Wilhemsen K, Gjesdal S. Occupational disability caused by dizziness and vertigo: a register-based prospective study. British Journal of General Practice. 2008;58(554):619-23.
Swain SK, Munjal S, Shajahan N. Vertigo in children: Our experiences at a tertiary care teaching hospital of eastern India. Journal of the Scientific Society. 2020;47(2):74-8.
Lundberg YW, Xu Y, Thiessen KD, Kramer KL. Mechanisms of otoconia and otolith development. Dev Dyn. 2015;244:239-53.
Arabi A, El Rassi R, El-Hajj Fuleihan G. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol. 2010;6(10):550-61.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81.
Neuhauser HK. The epidemiology of dizziness and vertigo. Handbook of clinical neurology. 2016;137:67-82.
Swain SK. Pharmacotherapy for vertigo: a current perspective. Int J Otorhinolaryngol Head Neck Surg. 2020;6(7):1400-6.
Rhim GI. Variables for one year recurrence of benign paroxysmal positional vertigo. Korean J Otorhinolaryngol Head Neck Surg. 2014;57:314-9.
Von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T, et al. Epidemiology of benign paroxysmal positional vertigo: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(7):710-5.
Swain SK. Revisiting pathophysiology of benign paroxysmal positional vertigo: a review. International Journal of Otorhinolaryngology and Head and Neck Surgery. 2023;9(4):355.
Bhattacharyya N, Gubbels SP, Schwartz SR, Edlow JA, El-Kashlan H, Fife T, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update) executive summary. Otolaryngology–Head and Neck Surgery. 2017;156(3):403-16.
Swain SK. Diagnostic Criteria of Benign Paroxysmal Positional Vertigo. Matrix Science Medica. 2023;7(4):85-9.
Ahmadieh H, Arabi A. Vitamins and bone health: beyond calcium and vitamin D. Nutr Rev. 2011;69(10):584-98.
Jeong SH, Choi SH, Kim JY, Koo JW, Kim HJ, Kim JS. Osteopenia and osteoporosis in idiopathic benign positional vertigo. Neurology.2009;72(12):1069-76.
Dhesi JK, Jackson SH, Bearne LM, Moniz C, Hurley MV, Swift CG, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing. 2004;33(6):589-95.
Rhim GI. Variables for one year recurrence of benign paroxysmal position al vertigo. Korean J Otorhinolaryngol Head Neck Surg. 2014;57:314-9.
Wangemann P. Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential. The Journal of physiology. 2006;576(1):11-21.
Buki B, Mandala M, Nuti D. Typical and atypical benign paroxysmal positional vertigo: literature review and new theoretical considerations. J Vestib Res. 2014;24:415-23.
Zhao X, Yang H, Yamoah EN, Lundberg YW. Gene targeting reveals the role of Oc90 as the essential organizer of the otoconial organic matrix. Dev Biol. 2007;304:508-24.
Yu S, Liu F, Cheng Z, Wang Q. Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review. BMC neurology. 2014;14:1-6.
Mikulec AA, Kowalczyk KA, Pfitzinger ME, Harris DA, Jackson LE. Negative association between treated osteoporosis and benign paroxysmal positional vertigo in women. J Laryngol Otol. 2010;124:374-6.
Ahmadieh H, Arabi A. Vitamins and bone health: beyond calcium and vitamin D. Nutr Rev. 2011;69:584-98.
Swain SK. Benign paroxysmal positional vertigo in patients with Meniere's disease. Saudi Journal of Otorhinolaryngology Head and Neck Surgery. 2022;24(2):51-5.
Swain SK. Diagnostic Criteria of Benign Paroxysmal Positional Vertigo. Matrix Science Medica. 2023;7(4):85-9.
Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. Cochrane Database Syst Rev. 2014(12):CD 003162.
Işık GC, Çevik Y, Emektar E, Çorbacıoğlu ŞK. Analysis of vitamin D and calcium levels in benign paroxysmal positional vertigo. Eurasian J Emerg Med. 2017, 16:128-32.
Yu S, Liu F, Cheng Z, Wang Q. Association between osteoporosis and benign paroxysmal positional vertigo: a systematic review. BMC neurology. 2014;14:1-6.
Swain SK. Audiovestibular manifestations during pregnancy: A review. Int J Res Med Sci. 2022;10(8):1809-4.
Resuli AS, Bedir A, Özgür A. The relationship between benign paroxysmal positional vertigo and vitamin D. Cureus. 2022;14(6):1-7.
Buki B, Ecker M, Junger H, Lundberg YW. Vitamin D deficiency and benign paroxysmal positioning vertigo. Eur Arch Otorhinolaryngol. 2013;80:201-4.
Talaat HS, Abuhadied G, Talaat AS, Abdelaal MSS. Low bone mineral density and vitamin D deficiency in patients with benign positional par oxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272:2249-53.
Swain SK. Meniere’s disease in the pediatric age group-a review. International Journal of Contemporary Pediatrics. 2022;9(7):693.
Swain SK. Current treatment of Meniere's disease. Matrix Sci Medica. 2023;7(1):1-6.
Wöbke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Frontiers Physiol. 2014;5:244.
Frejo L, Requena T, Okawa S, Gallego-Martinez A, Martinez-Bueno M, Aran I, et al. Regulation of Fn14 receptor and NF-κB underlies inflammation in Meniere’s disease. Frontiers Immunol. 2017;8:1739.
Tabtabai R, Haynes L, Kuchel GA, Parham K. Age-related increase in blood levels of Otolin-1 in humans. Otol Neurotol. 2017;38(6):865-9.
Shimizu S, Cureoglu S, Yoda S, Suzuki M, Paparella MM. Blockage of longitudinal flow in Meniere's disease: A human temporal bone study. Acta otolaryngologica. 2011;131(3):263-8.
Handzel O, Burgess BJ, Nadol Jr JB. Histopathology of the peripheral vestibular system after cochlear implantation in the human. Otol Neurotol. 2006;27(1):57-64.
Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmunity Rev. 2010;9(11):709-15.
Downloads
Published
How to Cite
Issue
Section
